Hearing Loss Risk and Your Genetics

By the ExomeDNA Science Team

This page contains general information only. For personal health decisions, consult a qualified clinician.

Sensorineural hearing loss is the most common form of permanent hearing loss, affecting roughly 1 in 5 adults worldwide and caused by damage to the cochlea, spiral ganglion neurons, or the auditory nerve rather than the middle ear. Below: what the science currently knows about the genetic contributors to this condition, which biological pathways matter most, and the evidence-backed steps that may help protect long-term hearing health.

What is sensorineural hearing loss?

Hearing loss comes in two fundamentally different forms. Conductive hearing loss arises from problems in the outer or middle ear — a blocked ear canal, perforated eardrum, or stiffened ossicles — and is often correctable with surgery or hearing aids. Sensorineural hearing loss (SNHL) is different. It originates inside the inner ear or along the auditory nerve, and it is generally permanent.

SNHL occurs when the sensory machinery of the cochlea deteriorates or when the neurons that carry sound signals to the brain begin to fail. The cochlea contains roughly 15,000 to 20,000 hair cells — tiny mechanosensory cells that convert the physical movement of sound waves into electrical signals. These hair cells do not regenerate in mammals. Once they die, that portion of the auditory range is lost permanently. Spiral ganglion neurons, the auditory neurons that relay hair cell signals along cranial nerve VIII to the brainstem, are equally irreplaceable and equally vulnerable.

SNHL typically affects high frequencies first, which is why early loss is often experienced as difficulty understanding speech in noisy environments rather than a global reduction in volume. Over time, lower frequencies can become involved as well. Because SNHL is irreversible, understanding susceptibility factors — including genetic ones — is considered an important step toward meaningful prevention.

ICD-10 code H90.5 captures unspecified sensorineural hearing loss, covering both unilateral and bilateral presentations. The trait measured on this page, derived from the PheCode classification system as PheCode 389.1, maps directly to this clinical category.

The genetics behind hearing loss risk

COL11A1 — the tectorial membrane scaffold

COL11A1 encodes collagen type XI alpha-1, a structural chain of the type XI heterotrimer collagen complex. In the inner ear, this collagen is the principal scaffolding protein of the tectorial membrane — the acellular, gelatinous structure that lies directly above the organ of Corti and makes contact with the stereocilia of outer hair cells. When sound enters the cochlea, fluid waves cause the basilar membrane to move. The tectorial membrane, resting on top of the hair cell bundle, deflects the stereocilia and triggers the electrochemical cascade that the brain interprets as sound.

COL11A1 variants that alter the mechanical properties of the tectorial membrane are thought to reduce its elasticity and coupling efficiency. High-frequency hearing, which depends on precise, fast tectorial membrane deflection at the basal cochlear turn, is most vulnerable to this kind of mechanical compromise. COL11A1 mutations in their severe forms cause Stickler syndrome type II and Marshall syndrome, both of which include sensorineural hearing loss as a core feature. Common variants catalogued by GWAS studies are not individually deterministic, but they appear to nudge tectorial membrane function in ways that accumulate over a lifetime.

EYA4 — hair cell survival

EYA4 (eyes absent homolog 4) is a transcriptional coactivator and phosphatase expressed in cochlear hair cells and their supporting cells. It functions by binding SIX homeodomain proteins and activating gene programs essential for inner ear development and maintenance. Rare EYA4 mutations cause DFNA10, autosomal dominant nonsyndromic sensorineural hearing loss that is progressive and typically begins in adulthood — the molecular picture of what gradual hair cell attrition looks like when this gene's dosage is insufficient.

Common EYA4 variants identified in population-level GWAS work may not produce the pronounced early-onset loss of DFNA10, but the biological logic is consistent: reduced EYA4 activity impairs the maintenance pathways that keep hair cells alive under the steady oxidative and mechanical stress of daily auditory exposure. Over decades, this difference in hair cell resilience can matter.

ACAN — spiral ganglion neuron support

ACAN encodes aggrecan, a large chondroitin-sulfate proteoglycan best known for its role in cartilage. In the nervous system, aggrecan is a principal component of perineuronal nets — dense extracellular matrix lattices that wrap around neuronal cell bodies and proximal dendrites. Spiral ganglion neurons, the auditory relay neurons that transmit cochlear signals to the brain, are surrounded by aggrecan-rich perineuronal nets that provide structural support and regulate ionic buffering in the auditory pathway. ACAN variants may influence the integrity of these protective matrices and, by extension, the long-term resilience of auditory neurons.

NID2 — basement membrane integrity

NID2 (nidogen-2) is a basement membrane glycoprotein that bridges collagen IV and laminin networks. Cochlear basement membranes underlie hair cells and spiral ganglion neurons, and their structural integrity is important for maintaining the cellular architecture of the inner ear. NID2 variants may affect the long-term stability of these supporting matrices.

MAST2 and SPTBN1 — neuronal maintenance pathways

MAST2 (microtubule-associated serine/threonine kinase 2) modulates PTEN phosphatase activity and neuronal PI3K/PTEN signaling, a pathway relevant to neuronal survival. SPTBN1 (spectrin beta-2) is a cytoskeletal scaffold protein that maintains axonal membrane organization in neurons, including those of the auditory nerve. Both genes point to auditory neuron health as a parallel axis of SNHL susceptibility alongside hair cell loss.

What the research says

Research base: Robust.

The genetic signals powering this trait come from a large-scale genome-wide association study published in 2024 in Nature Genetics (Verma A et al., PMID 39024449). The VA Million Veteran Program (MVP) is one of the largest biobank cohorts in the world, enrolling more than one million United States veterans. This particular analysis examined genetic architecture across 2,068 health traits, drawing on a diverse, multi-ancestry participant population with deep longitudinal health records — an important feature given that SNHL is typically identified after years of cumulative exposure.

Scale of the evidence:

• More than 1,000,000 participants enrolled in the VA Million Veteran Program at time of analysis
• Genetic associations examined across 2,068 phenotypes simultaneously, enabling robust cross-trait comparison
• Multi-ancestry design improves the generalizability of signal detection beyond predominantly European reference cohorts

Key findings relevant to SNHL:

1. COL11A1 emerged as a statistically significant locus for sensorineural hearing loss, consistent with its known structural role in the tectorial membrane and its established connection to syndromic hearing loss in rare variant studies.
2. EYA4 signals align with prior Mendelian genetics establishing this gene's necessity for cochlear hair cell maintenance and with the adult-onset progressive hearing loss phenotype of DFNA10.
3. ACAN, NID2, MAST2, and SPTBN1 associations point to a broader picture in which both the structural matrix supporting hair cells and the auditory neurons themselves are genetic contributors to SNHL susceptibility.
4. The multi-ancestry recruitment of the MVP cohort makes these findings more relevant across diverse genetic backgrounds than studies drawn from narrower reference populations.

It is important to note that GWAS signals identify statistical associations between common genetic variants and a phenotype in a population. They do not determine individual outcomes. Hearing loss is substantially shaped by environmental and behavioral factors — most prominently, noise exposure — that interact with genetic background in ways that are not fully characterized.

How hearing loss risk affects you

SNHL is typically a gradual process in which cumulative damage to cochlear hair cells and auditory neurons accumulates over years or decades before becoming clinically apparent. The form of SNHL that affects most adults is age-related hearing loss, called presbycusis, which reflects the interplay of genetic susceptibility, lifetime noise exposure, vascular health, and oxidative stress.

For individuals with genetic variants associated with elevated SNHL risk, the practical implication is not that hearing loss is inevitable. It is that the biological systems involved — tectorial membrane mechanics, hair cell survival pathways, auditory neuron extracellular matrix support — may be somewhat less resilient than average. Environmental stressors that damage these systems — primarily noise — therefore carry a proportionally higher expected impact.

Noise-induced hearing loss deserves particular emphasis. Sound pressure above approximately 85 decibels over extended periods physically damages cochlear hair cells. A single extremely loud event (140+ dB, such as a gunshot near the ear) can cause immediate permanent hair cell death. Because hair cells do not regenerate, this damage is additive. Every avoidable high-noise exposure represents hearing capacity that will not return.

Ototoxic medications — aminoglycoside antibiotics, loop diuretics, and platinum-based chemotherapy agents — are a second important environmental contributor to SNHL. These drugs damage hair cells through mechanisms that include oxidative stress and disruption of cochlear ion transport. For individuals with genetic variants that may already reduce hair cell resilience, ototoxic exposures may carry a heightened impact.

Vascular health is a third key axis. The cochlea has extremely high metabolic demands and depends on the stria vascularis — a vascular structure that maintains the ionic environment inside the cochlear duct — for continuous energy supply. Hypertension, diabetes, smoking, and other conditions that impair cochlear blood flow accelerate SNHL. This makes cardiovascular health relevant not only to heart and brain outcomes, but to hearing preservation as well.

Working with your hearing loss result

A higher genetic score on this trait indicates that the variant pattern observed in your genome statistically resembles those associated with elevated sensorineural hearing loss susceptibility in large population studies. It does not predict hearing loss outcomes for any individual. The following steps are organized from highest to lowest preventive impact, based on the current evidence base for SNHL prevention.

1. Prioritize hearing protection in noisy environments. Foam earplugs with a noise reduction rating (NRR) of 30 or higher and properly fitted noise-canceling hearing protection are the most evidence-supported interventions for preventing noise-induced hair cell death. Occupational noise exposure (construction, manufacturing, military service, live music) is a primary risk setting.
2. Follow the 60/60 rule for personal audio devices. Listening at 60% of maximum volume for no more than 60 minutes at a time substantially reduces cochlear exposure. Volume-limiting headphone settings are available on most modern devices and are especially recommended for children, whose lifetime exposure window is longer.
3. Discuss ototoxic medications with your clinician before use. When aminoglycosides, platinum-based chemotherapy, or high-dose loop diuretics are under consideration, raising your genetic susceptibility context with a clinician allows for shared decision-making about alternatives or monitoring.
4. Establish a baseline audiogram by age 50, and test annually with occupational noise exposure or family history of SNHL. Early detection of threshold shift allows for timely intervention before auditory nerve degeneration compounds the primary hair cell loss.
5. Pursue early hearing aid fitting if mild-to-moderate SNHL is detected. Evidence increasingly links untreated SNHL with accelerated auditory nerve degeneration, increased cognitive load, and elevated dementia risk. Early amplification supports auditory pathway stimulation and reduces these downstream risks.
6. Manage vascular risk factors. Blood pressure control, blood glucose management in diabetes, and smoking cessation all protect cochlear blood flow and reduce the vascular contribution to SNHL progression.

Related traits and genes

The cochlea and auditory pathway share biological infrastructure with other sensory and neurological systems, which is reflected in the genetic architecture of related traits on the ExomeDNA platform.

The vertigo and balance risk trait (TRAIT_066226) covers vestibular biology — the inner ear's balance apparatus — which occupies a different sensory compartment (the vestibular labyrinth) from the cochlea. While both compartments are housed in the inner ear and share some structural proteins, their cell populations, fluid dynamics, and genetic signals are largely distinct. COL11A1 has cochlea-specific expression patterns relevant to the tectorial membrane; OTOGL, a signal associated with vestibular function on the vertigo page, is associated with a different inner ear compartment.

Tinnitus frequently co-occurs with SNHL because tinnitus (phantom sound perception) often reflects the auditory cortex's response to reduced cochlear input, analogous to phantom limb sensation. The genetic overlap between SNHL and tinnitus susceptibility is an active area of research.

Cardiovascular traits — hypertension, type 2 diabetes, and related vascular conditions — share a biological relationship with SNHL through cochlear blood flow. Individuals with vascular genetic variants may carry elevated SNHL risk through this indirect pathway.

Genes relevant to this trait — COL11A1, EYA4, ACAN, NID2, MAST2, and SPTBN1 — appear in the ExomeDNA gene library with additional detail on their broader biological roles and associated traits.

Frequently asked questions

Is sensorineural hearing loss the same as age-related hearing loss? Presbycusis (age-related hearing loss) is the most common form of SNHL and is the type most relevant to this genetic trait. It reflects the cumulative effect of lifetime hair cell and auditory neuron attrition. Not all SNHL is age-related — noise-induced hearing loss, ototoxic drug exposure, and certain infections can cause SNHL at any age — but the genetic variants identified in GWAS studies like the VA Million Veteran Program are primarily studied in the context of cumulative, adult-onset hearing decline.

Can genetics alone predict whether someone will lose their hearing? No. Genetic variants associated with SNHL risk are probabilistic signals, not deterministic predictors. Hearing loss risk is substantially shaped by environmental exposures — particularly noise and ototoxic medications — and lifestyle factors including vascular health. A higher genetic score means the relevant biological systems may be somewhat less resilient, not that hearing loss is predetermined.

What does the COL11A1 gene actually do in the ear? COL11A1 produces a collagen chain that forms the structural backbone of the tectorial membrane, the acellular gel-like structure that overlies the organ of Corti in the cochlea. The tectorial membrane physically deflects the stereocilia of outer hair cells as sound waves move through the cochlear fluid. Without proper COL11A1 function, the tectorial membrane loses mechanical efficiency, particularly for high-frequency sounds, which require precise rapid deflection at the base of the cochlea.

Why does untreated hearing loss matter beyond the ability to hear? Untreated SNHL places ongoing cognitive strain on the brain as it works to fill in missing auditory information. This increased cognitive load has been associated in large observational studies with elevated dementia risk. Additionally, untreated SNHL allows progressive auditory nerve degeneration to continue without the stimulation that hearing aids and sound amplification provide. Early fitting with hearing aids, once mild-to-moderate SNHL is detected, is recommended for these reasons.

Are hearing aids effective at preventing further loss? Hearing aids do not reverse or halt hair cell damage, which is permanent. However, they restore auditory nerve stimulation in frequency ranges where hair cell function has declined, which may reduce secondary auditory nerve degeneration. They also substantially reduce the cognitive burden associated with effortful listening. Current evidence supports early fitting as beneficial for quality of life and, potentially, for cognitive outcomes.

What is the VA Million Veteran Program and why does it matter for this trait? The VA Million Veteran Program is a United States Department of Veterans Affairs biobank that has enrolled more than one million veterans for genomic and health research. Its scale and multi-ancestry design make it one of the most powerful platforms for discovering genetic signals associated with complex traits. The 2024 Verma et al. study (PMID 39024449) analyzed genetic architecture across 2,068 traits in this cohort, identifying the loci reported on this page. The large sample size and diversity of participants increase confidence that these signals generalize beyond any single ancestry group.

References

Verma A et al. (2024). Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Nature Genetics. PMID 39024449.

ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.